The influence of antibodies on Staphylococcus epidermidis adherence to polyvinylpyrrolidone-coated silicone elastomer in experimental biomaterial-associated infection in mice

Biomaterials

Volumn 30, Issue 32, 2009, Pages 6444-6450

  Broekhuizen, Corine A N ^a   de Boer, Leonie ^a   Schipper, Kim ^a   Jones, Christopher D ^b   Quadir, Shan ^b   Feldman, Robert G ^b   Vandenbroucke Grauls, Christina M J E ^a,c   Zaat, Sebastian A J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Emergent Biosolutions   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Accumulation associated protein (Aap); Biomaterial associated infection; Lipoteichoic acid (LTA); Monoclonal antibodies; Staphylococcus epidermidis

Indexed keywords

ACCUMULATION-ASSOCIATED PROTEIN (AAP); BACTERIAL ADHERENCE; CELL WALL PROTEINS; EPIDERMIDIS; IN-VITRO; LIPOTEICHOIC ACID (LTA); LIPOTEICHOIC ACIDS; MODERN MEDICINE; MONOCLONAL ANTIBODIES (MABS); PASSIVE IMMUNIZATION; POLY VINYL PYRROLIDONE; SILICONE ELASTOMERS; STAPHYLOCOCCUS EPIDERMIDIS; SURFACE PROTEINS;

ACIDS; ANTIGENS; CELL CULTURE; CELL MEMBRANES; IMMUNIZATION; MONOCLONAL ANTIBODIES; SILICONES; SURFACE PLASMON RESONANCE;

THERMOANALYSIS;

ACCUMULATION ASSOCIATED PROTEIN 1; ACCUMULATION ASSOCIATED PROTEIN 1 ANTIBODY; ACCUMULATION ASSOCIATED PROTEIN 2; ACCUMULATION ASSOCIATED PROTEIN 3; BACTERIUM ANTIBODY; BIOMATERIAL; CELL MEMBRANE PROTEIN; LIPOTEICHOIC ACID; LIPOTEICHOIC ACID ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MS1-34; MONOCLONAL ANTIBODY MS1-47; MONOCLONAL ANTIBODY MS2-89; POVIDONE; SILASTIC; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; CONTROLLED STUDY; DEVICE INFECTION; FEMALE; INFECTION PREVENTION; MATERIAL COATING; MOUSE; NONHUMAN; OPSONIZATION; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REPEATED DRUG DOSE; SINGLE DRUG DOSE; STAPHYLOCOCCUS EPIDERMIDIS;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL ADHESION; COATED MATERIALS, BIOCOMPATIBLE; MATERIALS TESTING; MICE; MICE, INBRED C57BL; POVIDONE; SILICONE ELASTOMERS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

BACTERIA (MICROORGANISMS); MUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 70249088999     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.08.018     Document Type: Article

References (50)

1. O'Gara J.P., and Humphreys H. Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol 50 7 (2001) 582-587
2. Crnich C.J., and Maki D.G. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis 34 9 (2002) 1232-1242
3. Mermel L.A. Prevention of intravascular catheter-related infections. Ann Intern Med 132 5 (2000) 391-402
4. Costerton J.W., Cheng K.J., Geesey G.G., Ladd T.I., Nickel J.C., Dasgupta M., et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 41 (1987) 435-464
5. Götz F. Staphylococcus and biofilms. Mol Microbiol 43 6 (2002) 1367-1378
6. Marrie T.J., and Costerton J.W. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J Clin Microbiol 19 5 (1984) 687-693
7. Frebourg N.B., Lefebvre S., Baert S., and Lemeland J.F. PCR-based assay for discrimination between invasive and contaminating Staphylococcus epidermidis strains. J Clin Microbiol 38 2 (2000) 877-880
8. Williams R.J., Henderson B., Sharp L.J., and Nair S.P. Identification of a fibronectin-binding protein from Staphylococcus epidermidis. Infect Immun 70 12 (2002) 6805-6810
9. Nilsson M., Frykberg L., Flock J.I., Pei L., Lindberg M., and Guss B. A fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun 66 6 (1998) 2666-2673
10. Mack D., Becker P., Chatterjee I., Dobinsky S., Knobloch J.K., Peters G., et al. Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus: functional molecules, regulatory circuits, and adaptive responses. Int J Med Microbiol 294 2-3 (2004) 203-212
11. Hussain M., Herrmann M., von Eiff C., Perdreau-Remington F., and Peters G.A. 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun 65 2 (1997) 519-524
12. Rohde H., Burdelski C., Bartscht K., Hussain M., Buck F., Horstkotte M.A., et al. Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol Microbiol 55 6 (2005) 1883-1895
13. Banner M.A., Cunniffe J.G., Macintosh R.L., Foster T.J., Rohde H., Mack D., et al. Localized tufts of fibrils on Staphylococcus epidermidis NCTC 11047 are comprised of the accumulation-associated protein. J Bacteriol 189 7 (2007) 2793-2804
14. Boelens J.J., Dankert J., Murk J.L., Weening J.J., van der Poll T., Dingemans K.P., et al. Biomaterial-associated persistence of Staphylococcus epidermidis in pericatheter macrophages. J Infect Dis 181 4 (2000) 1337-1349
15. Boelens J.J., Zaat S.A.J., Meeldijk J., and Dankert J. Subcutaneous abscess formation around catheters induced by viable and nonviable Staphylococcus epidermidis as well as by small amounts of bacterial cell wall components. J Biomed Mater Res 50 (2000) 546-556
16. Broekhuizen C.A.N., de Boer L., Schipper K., Jones C.D., Quadir S., Feldman R.G., et al. Peri-implant tissue is an important niche for Staphylococcus epidermidis in experimental biomaterial-associated infection in mice. Infect Immun 75 3 (2007) 1129-1136
17. Broekhuizen C.A.N., de Boer L., Schipper K., Jones C.D., Quadir S., Vandenbroucke-Grauls C.M., et al. Staphylococcus epidermidis is cleared from biomaterial implants but persists in peri-implant tissue in mice despite rifampicin/vancomycin treatment. J Biomed Mater Res A 85 2 (2008) 498-505
18. Broekhuizen C.A.N., Schultz M.J., van der Wall A., Boszhard L., Vandenbroucke-Grauls C.M.J.E., and Zaat S.A.J. Tissue around catheters is a niche for bacteria associated with medical device infection. Crit Care Med 36 (2008) 2395-2402
19. Cerca N., Jefferson K.K., Oliveira R., Pier G.B., and Azeredo J. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun 74 8 (2006) 4849-4855
20. Cerca N., Jefferson K.K., Maira-Litran T., Pier D.B., Kelly-Quintos C., Goldmann D.A., et al. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun 75 7 (2007) 3406-3413
21. McKenney D., Pouliot K.L., Wang Y., Murthy V., Ulrich M., Doring G., et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 284 5419 (1999) 1523-1527
22. Christensen G.D., Simpson W.A., Bisno A.L., and Beachey E.H. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun 37 1 (1982) 318-326
23. Hebert G.A., and Hancock G.A. Synergistic hemolysis exhibited by species of staphylococci. J Clin Microbiol 22 3 (1985) 409-415
24. Vandecasteele S.J., Peetermans W.E., Merckx R., Rijnders B.J., and Van Eldere J. Reliability of the ica, aap and atlE genes in the discrimination between invasive, colonizing and contaminant Staphylococcus epidermidis isolates in the diagnosis of catheter-related infections. Clin Microbiol Infect 9 2 (2003) 114-119
25. Boelens J.J., Zaat S.A.J., Murk J.L., Weening J.J., Van der Poll T., and Dankert J. Enhanced susceptibility to subcutaneous abscess formation and persistent infection around catheters is associated with sustained interleukin-1beta levels. Infect Immun 68 3 (2000) 1692-1695
26. Boelens J.J., Van der Poll T., Dankert J., and Zaat S.A.J. Interferon-gamma protects against biomaterial-associated infection in mice. J Infect Dis 181 (2000) 1167-1171
27. Fleck R.A., Romero-Steiner S., and Nahm M.H. Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies. Clin Diagn Lab Immunol 12 1 (2005) 19-27
28. Guttormsen H.K., Liu Y., and Paoletti L.C. Functional activity of antisera to group B streptococcal conjugate vaccines measured with an opsonophagocytosis assay and HL-60 effector cells. Hum Vaccin 4 5 (2008) 370-374
29. Romero-Steiner S., Libutti D., Pais L.B., Dykes J., Anderson P., Whitin J.C., et al. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol 4 4 (1997) 415-422
30. Romero-Steiner S., Frasch C.E., Carlone G., Fleck R.A., Goldblatt D., and Nahm M.H. Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin Vaccine Immunol 13 2 (2006) 165-169
31. Fattom A.I., Sarwar J., Ortiz A., and Naso R. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect Immun 64 5 (1996) 1659-1665
32. Kelly-Quintos C., Cavacini L.A., Posner M.R., Goldmann D., and Pier G.B. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun 74 5 (2006) 2742-2750
33. Kojima Y., Tojo M., Goldmann D.A., Tosteson T.D., and Pier G.B. Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci. J Infect Dis 162 2 (1990) 435-441
34. Lee J.C., Park J.S., Shepherd S.E., Carey V., and Fattom A. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect Immun 65 10 (1997) 4146-4151
35. Sellman B.R., Howell A.P., Kelly-Boyd C., and Baker S.M. Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis. Infect Immun 73 10 (2005) 6591-6600
36. Vernachio J.H., Bayer A.S., Ames B., Bryant D., Prater B.D., Syribeys P.J., et al. Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo. Antimicrobial Agents Chemother 50 2 (2006) 511-518
37. Rohde H., Burandt E.C., Siemssen N., Frommelt L., Burdelski C., Wurster S., et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 28 9 (2007) 1711-1720
38. Bowden M.G., Chen W., Singvall J., Xu Y., Peacock S.J., Valtulina V., et al. Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis. Microbiology 151 Pt 5 (2005) 1453-1464
39. Monk A.B., and Archer G.L. Use of outer surface protein repeat regions for improved genotyping of Staphylococcus epidermidis. J Clin Microbiol 45 3 (2007) 730-735
40. Rice K., Huesca M., Vaz D., and McGavin M.J. Variance in fibronectin binding and fnb locus polymorphisms in Staphylococcus aureus: identification of antigenic variation in a fibronectin binding protein adhesin of the epidemic CMRSA-1 strain of methicillin-resistant S. aureus. Infect Immun 69 6 (2001) 3791-3799
41. Domanski P.J., Patel P.R., Bayer A.S., Zhang L., Hall A.E., Syribeys P.J., et al. Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureus. Infect Immun 73 8 (2005) 5229-5232
42. Mukherjee J., Scharff M.D., and Casadevall A. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Infect Immun 63 9 (1995) 3353-3359
43. Jong E.C., and Zuckerman L.N. Traveller's vaccines: B.C. Decker incorporated (2004), Canada, Hamilton
44. Maira-Litran T., Kropec A., Goldmann D.A., and Pier G.B. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun 73 10 (2005) 6752-6762
45. Tamura Y., Kijima M., Ohishi K., Takahashi T., Suzuki S., and Nakamura M. Antigenic analysis of Clostridium chauvoei flagella with protective and non-protective monoclonal antibodies. J Gen Microbiol 138 3 (1992) 537-542
46. Sun D., Accavitti M.A., and Bryers J.D. Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein. Clin Diagn Lab Immunol 12 1 (2005) 93-100
47. Herrmann M., Lai Q.J., Albrecht R.M., Mosher D.F., and Proctor R.A. Adhesion of Staphylococcus aureus to surface-bound platelets: role of fibrinogen/fibrin and platelet integrins. J Infect Dis 167 2 (1993) 312-322
48. Niemann S., Spehr N., Van Aken H., Morgenstern E., Peters G., Herrmann M., et al. Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets. Circulation 110 2 (July 13, 2004) 193-200
49. Weisman L.E. Antibody for the prevention of neonatal noscocomial staphylococcal infection: a review of the literature. Arch Pediatr 14 Suppl. 1 (2007) S31-S34
50. Weisman L.E., Fischer G.W., Thackray H.M., Johnson K.E., Schuman R.F., Mandy G.T., et al. Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults. Int Immunopharmacol 9 5 (2009) 639-644